Evidence map›Paper›PMID 38786196›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Emergence of

Meiping Ye, Linxin Yao, Xinying Lu, Fangyuan Ding, Danyang Zou, Tingli Tian, Yi Lin, Zhen Ning, Jianping Jiang, Pingyu Zhou

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Inferring Sexual Network Bridging Using Genomics: A Simulation Study.medRxiv : the preprint server for health sciences · 2026
    Article
  3. In Vitro Activity of Zoliflodacin AgainstAntibiotics (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Meiping YeDepartment of Dermatology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China.
Linxin YaoSTD Institute, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China.
Xinying LuDepartment of Dermatology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China.
Fangyuan DingSTD Institute, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China.
Danyang ZouSTD Institute, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China.
Tingli TianSTD Institute, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China.
Yi LinDivision of Tuberculosis and HIV/AIDS Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200051, China.
Zhen NingDivision of Tuberculosis and HIV/AIDS Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200051, China.
Jianping JiangInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai 200040, China.ORCID 0000-0002-1066-6362
Pingyu ZhouDepartment of Dermatology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China.

Funding

National Natural Science Foundation of China 82072322National Natural Science Foundation of China 82172319Three-Year Initiative Plan for Strengthening Public Health System Construction in Shanghai GWV-10.2-YQ02
6 · The paper itself

Abstract

Drug-resistant

Indexed as

Neisseria gonorrhoeaereduced susceptibilitysitafloxacinST8123

Identifiers

PMID38786196
PMCPMC11118021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.